Novanta Stock Is Trading Higher On Q1 Earnings Beat, Strong Guidance

  • Novanta Inc NOVT reported first-quarter FY21 revenue growth of 4.6% year-on-year to $162.6 million, beating the analyst consensus of $156.3 million.
  • Photonics revenue rose 6.1% Y/Y to $58.5 million, Vision revenue declined 2% Y/Y to $67.6 million, while Precision Motion revenue rose 16.4% Y/Y to $36.5 million.
  • Adjusted operating income rose 7% Y/Y to $22.8 million, with margin expanding by 30 basis points to 14.02%.
  • Adjusted EBITDA rose 18.5% Y/Y to $32.7 million.
  • Adjusted EPS of $0.58 beat the analyst consensus of $0.39.
  • Novanta generated $23.3 million in operating cash flow and held $113.6 million in cash and equivalents.
  • Demand accelerated across multiple application areas, particularly in the advanced industrial sector, demonstrated in its record sales and bookings performance, with bookings increasing 28% Q/Q and 25% Y/Y, CEO Matthijs Glastra said.
  • The innovation programs were on track and making good progress, and it launched five new products in the quarter. 
  • Guidance: Novanta sees Q2 revenue guidance of $162 million - $165 million, above the analyst consensus of $158.55 million, and adjusted EBITDA outlook of $32 million - $34 million. 
  • It expects Q2 adjusted EPS of $0.49 - $0.53, compared to the analyst consensus of $0.50.
  • Novanta sees FY21 revenue guidance of $645 million - $655 million, above the analyst consensus of $644.35 million, and adjusted EBITDA guidance of $127 million - $134 million. It expects adjusted EPS of $2.04 - $2.19, compared to the analyst consensus of $2.11.
  • Price action: NOVT shares traded higher by 2.51% at $128.52 on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceTechMediaBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!